Results 271 to 280 of about 664,442 (399)

Telestroke and Timely Treatment and Outcomes in Patients With Acute Ischemic Stroke.

JAMA Netw Open
Stamm B, Whitney RT, Royan R, Ibrahim G, Nickles AV, Ferber RA, Ye W, Hsu WL, Chhabra N, Hayward RA, McDermott M, Scott PA, Sheth KN, Reeves MJ, Levine DA.   +14 more
europepmc   +1 more source

Clinical efficacy of edaravone dexborneol in the treatment of acute ischemic stroke: meta-analysis. [PDF]

Front Neurol
Gao H, Tan H, Wang J, Yang D, Liu Y, Wu T.   +5 more
europepmc   +1 more source

Cooling for Acute Ischemic Brain Damage (COOL AID): Preliminary Efficacy Data of Moderate Hypothermia For Acute Ischemic Stroke [PDF]

, 2001
Alex Abou‐Chebl, Michael A. De Georgia, Derk Krieger   +2 more
openalex   +1 more source

Application and Interpretation of High-Sensitivity Cardiac Troponin Assays in Patients With Acute Ischemic Stroke

Stroke, 2015
J. Scheitz, C. Nolte, U. Laufs, M. Endres   +3 more
semanticscholar   +1 more source

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

Thrombus composition and distribution patterns by thrombus volume in acute ischemic stroke. [PDF]

Front Neurol
Yun J, Jung JW, Kim KH, Nam HS, Heo J, Lee H, Kim BM, Kim DJ, Baik M, Yoo J, Kim J, Park H, Sohn SI, Hong JH, Song TJ, Chang Y, Seo JH, Kim GS, Seo KD, Ahn SH, Baek JH, Cho HJ, Choi JK, Jung YH, Cho BH, Kwon I, Heo JH, Kim YD.   +27 more
europepmc   +1 more source

Thrombolysis and conventional antithrombotic therapy in the management of acute ischemic stroke.

, 2000
Yukihiro Yoneda, Masayasu Tabuchi, Etsuro Mori   +2 more
openalex   +2 more sources

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou, Emily Bozenhardt, Gregory E. Alexander, Matthew L. Zierhut, Samira Merali, Antoinette Ajavon‐Hartmann, Peter Zannikos, Hyunmoon Back, EunYoung Suh, Navin Goyal, Mahesh N. Samtani, Alexei N. Plotnikov, Chandni Valiathan   +12 more
wiley   +1 more source

Neutrophil extracellular traposis in cancer patients with acute ischemic stroke. [PDF]

PLoS One
Hyun JW, Payumo RMP, Chung J, Kang YR, Kim SH, Kim HJ, Han JY, Park SY.   +7 more
europepmc   +1 more source

Sensitivity of Diffusion- and Perfusion-Weighted Imaging for Diagnosing Acute Ischemic Stroke Is 97.5%

Stroke, 2015
C. Simonsen, M. Madsen, M. L. Schmitz, I. Mikkelsen, M. Fisher, G. Andersen   +5 more
semanticscholar   +1 more source